---
title: "NKTR.US (NKTR.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NKTR.US/news.md"
symbol: "NKTR.US"
name: "NKTR.US"
parent: "https://longbridge.com/en/quote/NKTR.US.md"
datetime: "2026-06-13T16:34:00.889Z"
locales:
  - [en](https://longbridge.com/en/quote/NKTR.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NKTR.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NKTR.US/news.md)
---

# NKTR.US (NKTR.US) — Related News

### [Is Nektar (NKTR) Betting Its Immunology Future on Rezpegaldesleukin’s Ambitious ZENITH-AD Phase 3 Program?](https://longbridge.com/en/news/289087155.md)
*2026-06-08T17:33:18.000Z*
> Nektar Therapeutics is launching the Phase 3 ZENITH-AD program for rezpegaldesleukin in atopic dermatitis, with trials s

### [Nektar Stockholders Approve Governance and Incentive Plan Changes](https://longbridge.com/en/news/288910591.md)
*2026-06-05T22:27:28.000Z*
> Nektar Therapeutics stockholders approved governance changes, including electing Howard W. Robin to the board and amendi

### [Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NKTR Stock News](https://longbridge.com/en/news/288622904.md)
*2026-06-03T12:15:30.000Z*
> Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NKTR Stock News

### [Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York | NKTR Stock News](https://longbridge.com/en/news/287827653.md)
*2026-05-27T14:15:00.000Z*
> Nektar Therapeutics (Nasdaq: NKTR) will webcast its participation in the 2026 Jefferies Global Healthcare Conference in 

### [5 Healthcare Stocks Set to Join the Russell 3000](https://longbridge.com/en/news/287611352.md)
*2026-05-26T09:22:15.000Z*
> FTSE Russell has announced preliminary changes to the Russell 3000 Index, adding several healthcare stocks including Ocu

### [What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch](https://longbridge.com/en/news/287440530.md)
*2026-05-23T21:00:18.000Z*
> Prosight Management increased its stake in Nektar Therapeutics by 180,367 shares, valued at approximately $10.27 million

### [3 Best Healthcare Stocks to Buy in May 2026, According to Analysts](https://longbridge.com/en/news/286619134.md)
*2026-05-15T21:28:05.000Z*
> Healthcare stocks are back in focus this month as investors look for strong pipelines and steady growth in a market stil

### [Assessing Nektar Therapeutics (NKTR) Valuation After Its Recent Share Price Recovery](https://longbridge.com/en/news/286239931.md)
*2026-05-13T10:15:09.000Z*
> Nektar Therapeutics (NKTR) has gained attention due to a recent share price recovery, currently at $78.43, despite a mix